Sabine Vogel-Ziebolz

Title: Sabine Vogel-Ziebolz: Innovator in Cardiac Health Diagnostics

Introduction

Sabine Vogel-Ziebolz is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of cardiac health diagnostics, particularly in the early assessment of heart failure. Her innovative work focuses on the use of biomarkers to predict and diagnose heart conditions.

Latest Patents

Sabine Vogel-Ziebolz holds a patent titled "Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure." This patent outlines methods and systems for diagnosing functional and/or structural abnormalities of the heart that precede heart failure. The invention involves measuring cardiac troponin in a sample and comparing the measurement to a reference value. Additionally, other markers, including GDF15 and IGFBP7, are also measured in some embodiments.

Career Highlights

Sabine is currently employed at Roche Diagnostics Operations, Inc., where she continues to advance her research in cardiac diagnostics. Her work has been instrumental in developing methods that enhance the understanding of heart failure and its early indicators.

Collaborations

Throughout her career, Sabine has collaborated with notable colleagues, including Ursula-Henrike Wienhues-Thelen and Dirk Block. These collaborations have contributed to the advancement of innovative solutions in the medical field.

Conclusion

Sabine Vogel-Ziebolz is a key figure in the realm of cardiac health diagnostics, with her patent reflecting her commitment to improving patient outcomes. Her contributions are vital in the ongoing fight against heart failure, showcasing the importance of innovation in healthcare.